Impact of cross-irradiation on single time-point dosimetry in 177Lu-PSMA therapy

被引：0
|
作者：
Vergnaud, L. [1 ]
Badel, J. [2 ]
Giraudet, A. [2 ]
Sarrut, D. [1 ]
机构：
[1] CREATIS Lab, Villeurbanne, France
[2] Ctr Leon Berard, Lyon, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0930
引用
收藏
页码：S804 / S804
页数：1
相关论文
共 50 条
  • [31] Comparative preclinical biodistribution, dosimetry and endoradiotherapy in mCRPC of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Yusufi, N.
    Nekolla, S.
    Wurzer, A.
    Herz, M.
    D'Alessandria, C.
    Weber, W.
    Wester, H. J.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S642 - S643
  • [32] On the Quantitative Accuracy of xSPECT Quant Based Renal Uptake Determination for Internal Dosimetry in 177Lu-PSMA Radioligand Therapy
    Tran-Gia, Johannes
    Neumayer, Hashan
    Lassmann, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [33] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [34] Feasibility and reliability assessment of single imaging time-point for organ and tumour dosimetry following 177Lu-DOTATATE PRRT
    Konuparamban, Acsah
    Nautiyal, Amit
    Jha, Ashish
    Srichandan, Tusharkanta
    Mithun, Sneha
    Rangarajan, Venkatesh
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [35] Dosimetric evaluation of the lacrimal glands in patients undergoing therapy with 177Lu-PSMA
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Groener, D.
    Bockisch, B.
    Ngoc, C. Nguyen
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S102 - S103
  • [36] 177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor
    Has Simsek, Duygu
    Civan, Caner
    Ekenel, Meltem
    Kuyumcu, Serkan
    Sanli, Yasemin
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : 415 - 418
  • [37] Unraveling the Impact of 177Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation
    Kumar, Aravid S. Ravi
    Hofman, Michael S.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (01) : 85 - 86
  • [38] Initial experience with 177Lu-PSMA therapy for patients with advanced liver cancer
    Assadi, M.
    Rekabpour, S.
    Jafari, E.
    Shakibazad, N.
    Ahmadzadehfar, H.
    Alipour, Z.
    Amini, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S693 - S693
  • [39] Outcome-Driven Assessment of Single-Time Point Dosimetry for 177Lu-PSMA-617RPT
    Hu, J.
    Seifert, R.
    Xue, S.
    Ferreira, C.
    Afshar-Ormieh, A.
    Rominger, A.
    Shi, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S71 - S71
  • [40] First Experiences with 177Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single Patients
    Prasad, Vikas
    Zengerling, Friedemann
    Steinacker, Jochen P.
    Bolenz, Christian
    Beer, Meinrad
    Wiegel, Thomas
    Eiber, Matthias
    Fleshner, Neil
    Beer, Ambros J.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (07) : 975 - 979
12345